Stem cell therapy in inflammatory bowel diseases: an overview of succe…

페이지 정보

profile_image
작성자 Juliana
댓글 0건 조회 28회 작성일 25-01-25 21:33

본문

The development of organoid methods in regenerative medicine. The absence or abnormal activation of resident SCS in the intestine is capable of leading to intestinal epithelial dysfunction and immune dysfunction, as well as still to https://stemcelltreatmentguide.com/, which are key pathogenetic factors of IBD.

댓글목록

등록된 댓글이 없습니다.